Diligent Investors, LLC Gilead Sciences, Inc. Transaction History

Diligent Investors, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$73.27 - $83.09 $181,636 - $205,980	2,479 New	2,479 $200,000
Q4 2022 Jan 20, 2023	BUY	$62.32 - $89.47 $145,828 - $209,359	2,340 New	2,340 $0
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $190,117 - $216,629	-3,356 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $9,252 - $11,633	149 Added 4.65%	3,356 $212,000
Q2 2020 Jul 09, 2020	BUY	$72.34 - $84.0 $2,170 - $2,520	30 Added 0.94%	3,207 $247,000
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $24,926 - $31,927	-398 Reduced 11.13%	3,177 $238,000
Q4 2019 Jan 13, 2020	BUY	$61.62 - $67.78 $6,408 - $7,049	104 Added 3.0%	3,575 $232,000
Q3 2019 Oct 22, 2019	BUY	$62.51 - $69.0 $14,127 - $15,594	226 Added 6.96%	3,471 $220,000
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $6,372 - $7,146	-103 Reduced 3.08%	3,245 $219,000
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $209,350 - $234,527	3,348 New	3,348 $218,000
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $166,848 - $217,724	-2,756 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $23,878 - $26,438	-335 Reduced 10.84%	2,756 $213,000
Q2 2018 Jul 23, 2018	SELL	$64.88 - $75.68 $7,136 - $8,324	-110 Reduced 3.44%	3,091 $219,000
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $5,463 - $6,660	75 Added 2.4%	3,201 $241,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $4,269 - $5,011	-60 Reduced 1.88%	3,126 $224,000
Q3 2017 Nov 09, 2017	SELL	$72.11 - $85.47 $14,422 - $17,094	-200 Reduced 5.91%	3,186 $258,000
Q2 2017 Aug 11, 2017	BUY	N/A	3,386	3,386 $240,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Diligent Investors, LLC with notifications on news.